The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

RMD FINANCIAL STATEMENTS

ResMed Inc — balance sheet, income statement and cash flow trends

RMDResMed Inc

🇺🇸 USA · US · Healthcare · Medical Instruments & Supplies

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
02 B4 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue5.7 B $Gross Profit3.5 B $ · 61%Operating Income1.9 B $ · 33%Pre-tax Income1.9 B $ · 34%Net Income to Owners1.5 B $ · 27%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue5.7 B $+9.9%
Gross Profit3.5 B $+13.0%
Operating Income1.9 B $+12.3%
EBITDA1.9 B $-1.9%
Net Income to Owners1.5 B $+8.8%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
02.5 B5 B7.5 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets9 B
  • Equity6.6 B $73%
  • Current Liabilities1.4 B $16%
  • Long-term Liabilities985.4 M $11%

Key Figures

YoY change
Total Assets9 B $+9.7%
Total Liabilities2.4 B $+7.9%
Total Equity6.6 B $+10.3%
Cash & ST Investments1.5 B $+21.5%
Total Debt825.9 M $-3.0%
Net Debt-643.3 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
01 B2 B3 B202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
01 B2 B3 B3.2 B $Operating-706.7 M $Investing-1.8 B $Financing699.4 M $Net Change

Key Figures

YoY change
Operating Cash Flow3.2 B $+80.2%
Capital Expenditures267.5 M $+188.0%
Free Cash Flow2.9 B $+74.2%
Dividends Paid-612.2 M $-493.2%

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on RMD

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.